Disulfiram attenuates paraquat-induced hepatic injury and fibrotic remodeling by reducing oxidative stress and modulating NLRP3 and PGC-1α expression in rats

Abstract Purpose Paraquat (PQ) is a highly toxic herbicide that induces hepatic injury through oxidative stress, inflammasome activation, and progressive fibrosis, contributing to chronic liver disease. Drug repurposing offers a promising strategy for accelerating therapeutic development. This study evaluated the hepatoprotective and antifibrotic potential of disulfiram (DSF), a clinically approved drug with emerging antioxidant and anti-inflammatory properties, against PQ-induced hepatic injury, including its association with NLRP3 inflammasome activation and PGC-1α expression. Methods Thirty-five male Wistar rats were randomly assigned to seven groups: Control, Vehicle, DSF20, PQ (1.5 mg/kg), and PQ co-treated with DSF (5, 10, or 20 mg/kg). PQ and DSF were administered via intraperitoneal injection for 4 weeks (5 consecutive days per week, with 2-day intervals). Hepatic injury was evaluated using histopathology (H&E and Masson's trichrome staining), serum biomarkers (ALT, AST, and ALP), oxidative stress parameters (malondialdehyde [MDA], catalase [CAT], and glutathione peroxidase [GPx]), NLRP3 and PGC-1α gene expression determined by qRT-PCR, and quantitative fibrosis assessment (fibrosis score and fibrotic area percentage). Results PQ exposure caused marked hepatic histopathological injury, increased oxidative stress, elevated liver enzymes, increased NLRP3 expression, decreased PGC-1α expression, and elevated fibrosis. DSF co-treatment, particularly at 20 mg/kg, significantly ameliorated these changes by reducing tissue injury, lowering lipid peroxidation, restoring antioxidant enzyme activity, suppressing NLRP3 expression, restoring PGC-1α expression, and decreasing fibrosis score and fibrotic area. Notably, NLRP3 suppression was effective at both 10 and 20 mg/kg, whereas a significant reduction in fibrosis required 20 mg/kg. Conclusion Disulfiram, particularly at 20 mg/kg, significantly attenuated PQ-induced hepatic injury and fibrotic remodeling, accompanied by reduced oxidative stress, suppression of NLRP3 expression, and restoration of PGC-1α expression.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11568410/v1
Primary Topic
Paraquat toxicity studies and treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Disulfiram attenuates paraquat-induced hepatic injury and fibrotic remodeling by reducing oxidative stress and modulating NLRP3 and PGC-1α expression in rats

Zahra Babazadeh, Zohre Esmaeili, Hossein Najafzadehvarzi, Abdolreza Daraei et al.
2 links
Research Square
Paraquat toxicity studies and treatments
preprint

Disulfiram attenuates paraquat-induced hepatic injury and fibrotic remodeling by reducing oxidative stress and modulating NLRP3 and PGC-1α expression in rats

Zahra Babazadeh, Zohre Esmaeili, Hossein Najafzadehvarzi, Abdolreza Daraei, Mahtab Esmaeili, Hanieh Moghimi Kandelousi
preprint en

Abstract

Abstract Purpose Paraquat (PQ) is a highly toxic herbicide that induces hepatic injury through oxidative stress, inflammasome activation, and progressive fibrosis, contributing to chronic liver disease. Drug repurposing offers a promising strategy for accelerating therapeutic development. This study evaluated the hepatoprotective and antifibrotic potential of disulfiram (DSF), a clinically approved drug with emerging antioxidant and anti-inflammatory properties, against PQ-induced hepatic injury, including its association with NLRP3 inflammasome activation and PGC-1α expression. Methods Thirty-five male Wistar rats were randomly assigned to seven groups: Control, Vehicle, DSF20, PQ (1.5 mg/kg), and PQ co-treated with DSF (5, 10, or 20 mg/kg). PQ and DSF were administered via intraperitoneal injection for 4 weeks (5 consecutive days per week, with 2-day intervals). Hepatic injury was evaluated using histopathology (H&E and Masson's trichrome staining), serum biomarkers (ALT, AST, and ALP), oxidative stress parameters (malondialdehyde [MDA], catalase [CAT], and glutathione peroxidase [GPx]), NLRP3 and PGC-1α gene expression determined by qRT-PCR, and quantitative fibrosis assessment (fibrosis score and fibrotic area percentage). Results PQ exposure caused marked hepatic histopathological injury, increased oxidative stress, elevated liver enzymes, increased NLRP3 expression, decreased PGC-1α expression, and elevated fibrosis. DSF co-treatment, particularly at 20 mg/kg, significantly ameliorated these changes by reducing tissue injury, lowering lipid peroxidation, restoring antioxidant enzyme activity, suppressing NLRP3 expression, restoring PGC-1α expression, and decreasing fibrosis score and fibrotic area. Notably, NLRP3 suppression was effective at both 10 and 20 mg/kg, whereas a significant reduction in fibrosis required 20 mg/kg. Conclusion Disulfiram, particularly at 20 mg/kg, significantly attenuated PQ-induced hepatic injury and fibrotic remodeling, accompanied by reduced oxidative stress, suppression of NLRP3 expression, and restoration of PGC-1α expression.

Research Square
Babol University of Medical Sciences (IR)
Babol University of Medical Sciences, Vice Chancellor for Research and Technology, Kerman University of Medical Sciences
Good health and well-being
Paraquat toxicity studies and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon